GAMBARAN DERAJAT HISTOPATOLOGI PENDERITA MENINGIOMA DI MAKASSAR TAHUN 2018-2022

Mutmainnah Mutmainnah; Cahyono  Kaelan; Suryani  Tawali; Ni Ketut  Sungowati; Muhammad Husni Cangara; Upik Anderiani Miskad

doi:10.22487/htj.v10i2.1165

Authors

Mutmainnah Mutmainnah Universitas Hasanuddin
Cahyono Kaelan Departemen Patologi Anatomi, Fakultas Kedokteran, Universitas Hasanuddin
Suryani Tawali Departemen Kesehatan Masyarakat, Fakultas Kedokteran, Universitas Hasanuddin
Ni Ketut Sungowati Departemen Patologi Anatomi, Fakultas Kedokteran, Universitas Hasanuddin
Muhammad Husni Cangara Laboratorium Patologi Anatomi, Rumah Sakit Universitas Hasanuddin
Upik Anderiani Miskad Laboratorium Patologi Anatomi, Rumah Sakit Universitas Hasanuddin

DOI:

https://doi.org/10.22487/htj.v10i2.1165

Keywords:

Meningioma, Derajat histopatologi

Abstract

Meningioma merupakan suatu neoplasma dengan pertumbuhan lambat yang berasal dari sel-sel meningotelial lapisan araknoid. Meningioma dilaporkan merupakan tumor dengan insidensi tersering di Amerika Serikat, yaitu sekitar 36% dari seluruh tumor otak. Berdasarkan WHO, histopatologik meningioma terbagi dalam derajat 1 (jinak), derajat 2 (atipikal) dan 3 (ganas). Tujuan penelitian ini untuk melihat gambaran derajat histopatologi penderita meningioma di Makassar tahun 2018-2022. Penelitian kami menggunakan metode deskriptif, yang dilakukan di Makassar dari Januari 2018 hingga Desember 2022. Pada penelitian ini yang dinilai adalah usia, jenis kelamin, lokasi tumor, dan derajat histopatologi meningioma. Analisis data menggunakan software SPSS v.20. Sebanyak 200 sampel, usia 40-60 tahun paling banyak ditemukan yaitu 124 orang (62,0%), paling banyak jenis kelamin wanita yaitu 158 orang (79,0%), lokasi meningioma paling banyak berada di cerebri yaitu 83 orang (41,5%), serta meningioma derajat 1 merupakan yang terbanyak, yaitu 179 kasus (89,5%).

References

Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: A summary. Neuro Oncol. 2021;23(8):1231-1251. doi:10.1093/neuonc/noab106

Ye W, Ding-Zhong T, Xiao-Sheng Y, Ren-Ya Z, Yi L. Factors Related to the Post-operative Recurrence of Atypical Meningiomas. Front Oncol. 2020;10(503):1-7. doi:10.3389/fonc.2020.00503

Hutasoit GA, Sari P, Rupawan IK, Salman M. Tumor Phyllodes dan Prognosisnya. Heal Tadulako J. 2022;8(3):204-213. https://doi.org/10.22487/htj.v8i3.476

Fardillah N, Miskad UA, Cangara MH, Kaelan C, Ghaznawie M. Pola Ekspresi Protein P53 pada Astrositoma Berdasarkan Grading Histopatologi. Heal Tadulako J. 2023;9(2):148-156.

Backer-Grøndahl T, Moen BH, Torp SH. The histopathological spectrum of human meningiomas. Int J Clin Exp Pathol. 2012;5(3):231-242.

Kementerian Kesehatan Republik Indonesia. Pedoman Nasional Pelayanan Kedokteran Tumor Otak. Komite Penanggulangan Kanker Nasional; 2019.

J P Patel, T R Jansari VVC. Clinicopathological study of Meningioma. Trop J Pathol Microbiol. 2019;6(1):9-17.

Perry A, Louis D., Budka H, von Deimling A, Sahm F, Rushing E. Meningioma. In: WHO Classification of Tumours of The Central Nervous System. 4th ed. International Agency for Research on Cancer (IARC); 2016:232-245.

Cossu G, Messerer M, Parker F, Levivier M, Daniel RT. Meningiomas’ Management: An Update of the Literature. Neurooncology - Newer Dev. Published online 2016:361-372. doi:10.5772/62929

Fuller GN, Burger PC. Central nervous system. In: Histology for Pathologist. 4th ed. Wolters Kluwer Health Adis (ESP); 2012.

Ogasawara C, Philbrick BD, Adamson DC. Meningioma: A review of epidemiology, pathology, diagnosis, treatment, and future directions. Biomedicines. 2021;9(3):1-23. doi:10.3390/biomedicines9030319

Domingues P, González-Tablas M, Otero Á, et al. Genetic/molecular alterations of meningiomas and the signaling pathways targeted. Oncotarget. 2015;6(13):10671-10688. doi:10.18632/oncotarget.3870

Ostrom QT, Gittleman H, Fulop J, et al. CBTRUS statistical Report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro Oncol. 2015;17:iv1-iv62. doi:10.1093/neuonc/nov189

Wahyuhadi J, Heryani D, Basuki H. Risk of meningioma associated with exposure of hormonal contraception. A case control study. Maj Obstet Ginekol. 2018;26(1):36. doi:10.20473/mog.v26i12018.36-41

Shao Z, Liu L, Zheng Y, et al. Molecular Mechanism and Approach in Progression of Meningioma. Front Oncol. 2020;10(September):1-11. doi:10.3389/fonc.2020.538845

Goldbrunner R, Minniti G, Preusser M, et al. EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol. 2016;17(9):e383-e391. doi:10.1016/S1470-2045(16)30321-7

Ostrom QT, Cioffi G, Gittleman H, et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. Neuro Oncol. 2019;21:V1-V100. doi:10.1093/neuonc/noz150

Gangadhar K, Santhosh D, Fatterpekar G. Imaging Features of Intracranial Meningiomas with Histopathological Correlation: A Relook into Old Disease. Nepal J Radiol. 2013;3(1):14-32. doi:10.3126/njr.v3i1.8713

Bhat AR, Wani MA, Kirmani AR, Ramzan AU. Histological-subtypes and anatomical location correlated in meningeal brain tumors (meningiomas). J Neurosci Rural Pract. 2014;5(3):244-249. doi:10.4103/0976-3147.133568

Desai P, Patel D. A study of meningioma in relation to age, sex, site, symptoms, and computerized tomography scan features. Int J Med Sci Public Heal. 2015;5(2):331. doi:10.5455/ijmsph.2016.06102015124

Alama A, Barbieri F, Spaziante R, et al. Significance of cyclin D1 expression in meningiomas: A preliminary study. J Clin Neurosci. 2007;14(4):355-358. doi:10.1016/j.jocn.2006.04.001

Park JK. Epidemiology, pathology, clinical features, and diagnosis of meningioma. UpToDate Wolters Kluwer. Published 2023. Accessed August 7, 2022. https://www.uptodate.com/contents/epidemiology-pathology-clinical-features-and-diagnosis-of-meningioma

Lee KS, Zhang JJY, Kirollos R, Santarius T, Nga VDW, Yeo TT. A systematic review and meta-analysis of the association between cyproterone acetate and intracranial meningiomas. Sci Rep. 2022;12(1):1-11. doi:10.1038/s41598-022-05773-z

Talawo VY, Kaelan C, Miskad UA. Karakteristik klinis dan histopatologi meningioma di Makassar. Heal Tadulako J. 2023;9(1):81-86.

Kim MS, Kim KH, Lee EH, et al. Results of immunohistochemical staining for cell cycle regulators predict the recurrence of atypical meningiomas. J Neurosurg. 2014;121(5):1189-1200. doi:10.3171/2014.7.JNS132661

Goyal-Honavar A, Jayachandran R, Chacko G. Meningiomas - transition from traditional histological grading to molecular profiling in WHO CNS5: A Review. Indian J Pathol Microbiol. 2022;65(5):S83-S93. doi:10.4103/ijpm.ijpm_1085_21